Cargando…

FOXO1 locus and acetylcholinesterase inhibitors in elderly patients with Alzheimer’s disease

OBJECTIVE: Acetylcholinesterase inhibitors (AChEIs) may reduce the oxidative stress in brain of Alzheimer’s disease (AD) patients. Forkhead box O1 (FOXO1) protein has been reported as the link between oxidative stress and AD. We evaluated a potential association between FOXO1 gene locus and the resp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paroni, Giulia, Seripa, Davide, Fontana, Andrea, D’Onofrio, Grazia, Gravina, Carolina, Urbano, Maria, Cascavilla, Leandro, Pellegrini, Fabio, Greco, Antonio, Pilotto, Alberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4211854/ https://www.ncbi.nlm.nih.gov/pubmed/25364236 http://dx.doi.org/10.2147/CIA.S64758

Ejemplares similares

Hydroxytryptamine transporter gene-linked polymorphic region (5HTTLPR) is associated with delusions in Alzheimer’s disease
por: D’Onofrio, Grazia, et al.
Publicado: (2019)

Neurocognitive Disorders and Dehydration in Older Patients: Clinical Experience Supports the Hydromolecular Hypothesis of Dementia
por: Lauriola, Michele, et al.
Publicado: (2018)

Neuropsychiatric Symptoms, Endophenotypes, and Syndromes in Late-Onset Alzheimer's Disease: Focus on APOE Gene
por: Panza, Francesco, et al.
Publicado: (2011)

Relationship of Homocysteine Plasma Levels with Mild Cognitive Impairment, Alzheimer’s Disease, Vascular Dementia, Psychobehavioral, and Functional Complications
por: Lauriola, Michele, et al.
Publicado: (2021)

Effects of hypercapnia on peripheral vascular reactivity in elderly patients with acute exacerbation of chronic obstructive pulmonary disease
por: de Matthaeis, Angela, et al.
Publicado: (2014)

Role of the APOE polymorphism in carotid and lower limb revascularization: A prospective study from Southern Italy
por: Mastroianno, Sandra, et al.
Publicado: (2017)

CT-Detected MTA Score Related to Disability and Behavior in Older People with Cognitive Impairment
por: Lauriola, Michele, et al.
Publicado: (2022)

Nutrition, frailty, and Alzheimer's disease
por: Panza, Francesco, et al.
Publicado: (2014)

Vascular Schizophrenia-like Psychosis in Older Adults
por: Lauriola, Michele, et al.
Publicado: (2023)

Age-related hearing impairment and frailty in Alzheimer's disease: interconnected associations and mechanisms
por: Panza, Francesco, et al.
Publicado: (2015)

CYP2D6 genotypes in revolving door patients with bipolar disorders: A case series
por: Seripa, Davide, et al.
Publicado: (2018)

Potential fluid biomarkers for pathological brain changes in Alzheimer's disease: Implication for the screening of cognitive frailty
por: Ruan, Qingwei, et al.
Publicado: (2016)

Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer's Disease
por: Panza, Francesco, et al.
Publicado: (2016)

Altered Levels of Acetylcholinesterase in Alzheimer Plasma
por: García-Ayllón, María-Salud, et al.
Publicado: (2010)

New Acetylcholinesterase Inhibitors for Alzheimer's Disease
por: Mehta, Mona, et al.
Publicado: (2012)

Naturally Occurring Acetylcholinesterase Inhibitors and Their Potential Use for Alzheimer's Disease Therapy
por: dos Santos, Thaiane Coelho, et al.
Publicado: (2018)

Potential neuroimaging biomarkers of pathologic brain changes in Mild Cognitive Impairment and Alzheimer’s disease: a systematic review
por: Ruan, Qingwei, et al.
Publicado: (2016)

Extreme longevity variants at the FOXO3 locus may moderate FOXO3 isoform levels
por: Frankum, Ryan, et al.
Publicado: (2021)

N-Acetylcholinesterase-Induced Apoptosis in Alzheimer's Disease
por: Toiber, Debra, et al.
Publicado: (2008)

Involvement of APOE in Incidence of Revascularization in Patients Affected by Peripheral Arterial Disease: A Prospective Study from Southern Italy
por: Di Stolfo, Giuseppe, et al.
Publicado: (2023)

Alzheimer's Disease and Cognitive Frailty: Novel Therapeutic Technologies
por: D'Onofrio, Grazia, et al.
Publicado: (2016)

Genetic Profile, Environmental Exposure, and Their Interaction in Parkinson's Disease
por: Polito, Letizia, et al.
Publicado: (2016)

Correction to: Extreme longevity variants at the FOXO3 locus may moderate FOXO3 isoform levels
por: Frankum, Ryan, et al.
Publicado: (2021)

Language impairment in Alzheimer’s disease and benefits of acetylcholinesterase inhibitors
por: Ferris, Steven H, et al.
Publicado: (2013)

The State of The Art on Acetylcholinesterase Inhibitors in the Treatment of Alzheimer’s Disease
por: Vecchio, Immacolata, et al.
Publicado: (2021)

Heterologous Amyloid Seeding: Revisiting the Role of Acetylcholinesterase in Alzheimer's Disease
por: Jean, Létitia, et al.
Publicado: (2007)

Acetylcholinesterase Inhibition of Diversely Functionalized Quinolinones for Alzheimer’s Disease Therapy
por: Bautista-Aguilera, Óscar M., et al.
Publicado: (2020)

Molecular docking analysis of acetylcholinesterase inhibitors for Alzheimer's disease management
por: Hakeem, Israa J
Publicado: (2023)

Systemic Oxidative Stress and Conversion to Dementia of Elderly Patients with Mild Cognitive Impairment
por: Cervellati, Carlo, et al.
Publicado: (2014)

Discovery of Novel Acetylcholinesterase Inhibitors as Potential Candidates for the Treatment of Alzheimer’s Disease
por: Son, Minky, et al.
Publicado: (2019)

Inhibiting Acetylcholinesterase to Activate Pleiotropic Prodrugs with Therapeutic Interest in Alzheimer’s Disease
por: Toublet, François-Xavier, et al.
Publicado: (2019)

Molecular interaction of human acetylcholinesterase with trans-tephrostachin and derivatives for Alzheimer's disease
por: Pitchai, Arjun, et al.
Publicado: (2020)

Acetylcholinesterase Inhibitory Potential of Various Sesquiterpene Analogues for Alzheimer’s Disease Therapy
por: Arya, Ashwani, et al.
Publicado: (2021)

Efficacy of Acetylcholinesterase Inhibitors on Cognitive Function in Alzheimer’s Disease. Review of Reviews
por: Moreta, Marta Pérez-Gómez, et al.
Publicado: (2021)

Proposing novel natural compounds against Alzheimer’s disease targeting acetylcholinesterase
por: Girgin, Münteha, et al.
Publicado: (2023)

Efficacy of Souvenaid(®) Combined with Acetylcholinesterase Inhibitors in the Treatment of Mild Alzheimer’s Disease
por: García-Alberca, José María, et al.
Publicado: (2023)

Can a Positive Allosteric Modulation of GABAergic Receptors Improve Motor Symptoms in Patients with Parkinson's Disease? The Potential Role of Zolpidem in the Treatment of Parkinson's Disease
por: Daniele, Antonio, et al.
Publicado: (2016)

Acetylcholinesterase inhibitor modifications: a promising strategy to delay the progression of Alzheimer's disease
por: Bhattacharya, Soumee, et al.
Publicado: (2015)

Metal based donepezil analogues designed to inhibit human acetylcholinesterase for Alzheimer’s disease
por: Junaid, Md., et al.
Publicado: (2019)

Novel Acetylcholinesterase Inhibitors Based on Uracil Moiety for Possible Treatment of Alzheimer Disease
por: Semenov, Vyacheslav E., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vh8rl8ubtlvmsnmr62gnbppgio